Examines FDA’s new fast-track drug approval program that reduces review times from standard protocols. Raises questions about safety oversight balance between medical innovation speed and thorough regulatory assessment procedures.
FDA Approves First Drug Under New Fast-Track Review Program
Examines FDA’s new fast-track drug approval program that reduces review times from standard protocols. Raises questions about safety oversight balance between medical innovation speed and thorough regulatory assessment procedures. Read…